Amgen 20. Mai 2026 Amgen CFO Transition as Peter Griffith Retires, Thomas Dittrich Returns - Contract Pharma
Amgen 20. Mai 2026 Amgen, bidding adieu to CFO, lures Galderma exec with hefty $12.4M bonus - Fierce Pharma
Amgen 19. Mai 2026 Amgen Inc. stock (US0311621009): weight-loss data and earnings keep biotech in focus - AD HOC NEWS
Amgen 19. Mai 2026 Biopharma bites: IRA is here to stay, plus more safety concerns for Amgen's Tavneos - FirstWord Pharma
Amgen 18. Mai 2026 Høeg fired in latest FDA shakeup; 20 people die after taking Amgen drug - BioPharma Dive
Amgen 18. Mai 2026 Amgen Inc. stock (US0311621009): earnings beat, dividend and guidance keep biotech giant in focus - AD HOC NEWS
Amgen 16. Mai 2026 Amgen Inc stock (US0311621009): lungs cancer setback meets steady biotech cash flow - AD HOC NEWS
Amgen 15. Mai 2026 Alumis pulls back from would-be rival to Amgen’s Tepezza after assessing prospects - Fierce Biotech
Amgen 14. Mai 2026 Amgen stock (US0311621009): Biotech leader navigates patent cliffs and pipeline momentum - AD HOC NEWS
Amgen 12. Mai 2026 This Week’s Biopharma News: Amgen Deepens US Manufacturing Push - The Medicine Maker
Amgen 10. Mai 2026 Quantum firm hailed by Amgen tech leader as an ‘extraordinary platform’ plans IPO - Fierce Biotech